AMYLASE CONCENTRATION IN DONOR GROUPS DEPENDING ON TITERS OF ANTI-SARS-CoV-2 IgG IN BLOOD PLASMA
DOI 10.17721/1728.2748.2023.93.18-21
Keywords:
amylase, C-reactive protein, anti-SARS-CoV-2 IgGAbstract
COVID-19 is a disease of the respiratory system; however, some patients experience multiorgan complications, including those of the digestive system. Many studies have focused on liver, bile duct and stomach dysfunctions during the SARS-CoV-2 infection. Currently, it is known that COVID-19 leads to changes in amylase concentration in the blood, which may be a prognostic factor for pancreatic damage; however, information regarding these clinical cases is limited. Our study aimed to determine the potential changes in total amylase, pancreatic amylase and C-reactive protein (CRP) levels in the blood of the donor groups with different titers of anti-SARS-CoV-2 IgG. Donor groups with titers of anti-SARS-CoV-2 IgG 10 ± 3 and 95 ± 5 Index (S/C) were characterized by an increase in total and pancreatic amylase concentrations compared to the donor group with titer of anti-SARS-CoV-2 IgG 0 Index (S/C). We assumed that multiorgan dysfunction developed through the acute inflammatory reactions caused by the SARS-CoV-2 infection. In particular, this may lead to pancreatic complications. To confirm this, we analyzed the CRP concentration in the donor group with the changes in amylase concentration compared to the donor group with titer 0 Index (S/C). The results obtained may be useful in medical practice for diagnosing complications in the post-COVID-19 period and f
References
Minodier, L., Masse, S., Capai, L. et al. Clinical and virological factors associated with gastrointestinal symptoms in patients with acute respiratory infection: a two-year prospective study in general practice medicine. BMC Infect Dis 2017; 17; 729. https://doi.org/10.1186/s12879-017-2823-9
Ye Q, Wang B, Zhang T, Xu J, Shang S. The mechanism and treatment of gastrointestinal symptoms in patients with COVID-19. Am J Physiol Gastrointest Liver Physiol. 2020;319(2):G245-G252. doi: 10.1152/ajpgi.00148.2020.
Nobel YR, Phipps M, Zucker J, Lebwohl B, Wang TC, Sobieszczyk ME, Freedberg DE. Gastrointestinal Symptoms and Coronavirus Disease 2019: A Case-Control Study From the United States. Gastroenterology. 2020;159(1):373-375. doi: 10.1053/j.gastro.2020.04.017.
Eldaly, A.S., Fath, A.R., Mashaly, S.M. et al. Acute pancreatitis associated with severe acute respiratory syndrome coronavirus-2 infection: a case report and review of the literature. J Med Case Reports. 2021; 15, 461. https://doi.org/10.1186/s13256-021-03026-7
Pribadi RR, Simadibrata M. Increased serum amylase and/or lipase in coronavirus disease 2019 (COVID-19) patients: Is it really pancreatic injury? JGH Open. 2020; 5(2):190-192. doi: 10.1002/jgh3.12436.
de-Madaria E, Siau K, Cárdenas-Jaén K. Increased Amylase and Lipase in Patients With COVID-19 Pneumonia: Don't Blame the Pancreas Just Yet! Gastroenterology. 2021; 160(5):1871. doi: 10.1053/j.gastro.2020.04.044.
Chen L, Zhao J, Peng J, Li X, Deng X, Geng Z, Shen Z, Guo F, Zhang Q, Jin Y, Wang L, Wang S. Detection of SARS-CoV-2 in saliva and characterization of oral symptoms in COVID-19 patients. Cell Prolif. 2020; 53(12):e12923. doi: 10.1111/cpr.12923.
Wang F, Wang H, Fan J, Zhang Y, Wang H, Zhao Q. Pancreatic Injury Patterns in Patients With Coronavirus Disease 19 Pneumonia. Gastroenterology. 2020 Jul;159(1):367-370. doi: 10.1053/j.gastro.2020.03.055.
Збірник методичних рекомендацій з використання тест наборів фірми виробника «Human». – Режим доступу до ресурсу: http://www.human.de/en/productNew/Clinical_Chemistry/Reagents_and_Consumables/Multipurpose_Reagents.php.
Mohit E, Rostami Z, Vahidi H. A comparative review of immunoassays for COVID-19 detection. Expert Rev Clin Immunol. 2021; 17(6):573-599. doi: 10.1080/1744666X.2021.
Ashok A, Faghih M, Singh VK. Mild Pancreatic Enzyme Elevations in COVID-19 Pneumonia: Synonymous With Injury or Noise? Gastroenterology. 2021; 160(5):1872. doi: 10.1053/j.gastro.2020.05.086.
Szatmary P, Arora A, Thomas Raraty MG, Joseph Dunne DF, Baron RD, Halloran CM. Emerging Phenotype of Severe Acute Respiratory Syndrome-Coronavirus 2-associated Pancreatitis. Gastroenterology. 2020; 159(4):1551-1554. doi: 10.1053/j.gastro.2020.05.069.
Liu F, Long X, Zhang B, Zhang W, Chen X, Zhang Z. ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection. Clin Gastroenterol Hepatol. 2020; 18(9):2128-2130.e2. doi: 10.1016/j.cgh.2020.04.040.
Stephens JR, Wong JLC, Broomhead R, Stümpfle R, Waheed U, Patel P, Brett SJ, Soni S. Raised serum amylase in patients with COVID-19 may not be associated with pancreatitis. Br J Surg. 2021; 108(4):e152-e153. doi: 10.1093/bjs/znaa168.
Liu L, Wei Q, Alvarez X, Wang H, Du Y, Zhu H, Jiang H, Zhou J, Lam P, Zhang L, Lackner A, Qin C, Chen Z. Epithelial cells lining salivary gland ducts are early target cells of severe acute respiratory syndrome coronavirus infection in the upper respiratory tracts of rhesus macaques. J Virol. 2011; 85(8):4025-30. doi: 10.1128/JVI.02292-10.
Li G, Liu T, Jin G, Li T, Liang J, Chen Q, Chen L, Wang W, Wang Y, Song J, Liang H, Zhang C, Zhu P, Zhang W, Ding Z, Chen X, Zhang B; Tongji Multidisciplinary Team for Treating COVID-19 (TTTC). Serum amylase elevation is associated with adverse clinical outcomes in patients with coronavirus disease 2019. Aging (Albany NY). 2021; 13(20):23442-23458. doi: 10.18632/aging.203653.
